134 related articles for article (PubMed ID: 20370685)
1. Inhibitors of the sphingosine kinase pathway as potential therapeutics.
Pitman MR; Pitson SM
Curr Cancer Drug Targets; 2010 Jun; 10(4):354-67. PubMed ID: 20370685
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the development of sphingosine kinase inhibitors.
Pitman MR; Costabile M; Pitson SM
Cell Signal; 2016 Sep; 28(9):1349-1363. PubMed ID: 27297359
[TBL] [Abstract][Full Text] [Related]
3. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
Gao P; Peterson YK; Smith RA; Smith CD
PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase 1 as an anticancer therapeutic target.
Gao Y; Gao F; Chen K; Tian ML; Zhao DL
Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
[TBL] [Abstract][Full Text] [Related]
5. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.
Pitman MR; Powell JA; Coolen C; Moretti PA; Zebol JR; Pham DH; Finnie JW; Don AS; Ebert LM; Bonder CS; Gliddon BL; Pitson SM
Oncotarget; 2015 Mar; 6(9):7065-83. PubMed ID: 25788259
[TBL] [Abstract][Full Text] [Related]
6. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
Yan G; Chen S; You B; Sun J
Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
[TBL] [Abstract][Full Text] [Related]
7. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S
Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117
[TBL] [Abstract][Full Text] [Related]
8. Discovery and evaluation of inhibitors of human sphingosine kinase.
French KJ; Schrecengost RS; Lee BD; Zhuang Y; Smith SN; Eberly JL; Yun JK; Smith CD
Cancer Res; 2003 Sep; 63(18):5962-9. PubMed ID: 14522923
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
Lee JW; Ryu JY; Yoon G; Jeon HK; Cho YJ; Choi JJ; Song SY; Do IG; Lee YY; Kim TJ; Choi CH; Kim BG; Bae DS
Int J Cancer; 2015 Jul; 137(1):221-9. PubMed ID: 25429856
[TBL] [Abstract][Full Text] [Related]
10. A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation.
Ren S; Xin C; Pfeilschifter J; Huwiler A
Cell Physiol Biochem; 2010; 26(1):97-104. PubMed ID: 20502009
[TBL] [Abstract][Full Text] [Related]
11. Roles, regulation and inhibitors of sphingosine kinase 2.
Neubauer HA; Pitson SM
FEBS J; 2013 Nov; 280(21):5317-36. PubMed ID: 23638983
[TBL] [Abstract][Full Text] [Related]
12. Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.
Alshaker H; Srivats S; Monteil D; Wang Q; Low CMR; Pchejetski D
Breast Cancer Res Treat; 2018 Nov; 172(1):33-43. PubMed ID: 30043096
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of sphingosine kinase-1 protects adipose tissue against LPS-induced inflammatory response in Zucker diabetic fatty rats.
Tous M; Ferrer-Lorente R; Badimon L
Am J Physiol Endocrinol Metab; 2014 Sep; 307(5):E437-46. PubMed ID: 25053402
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel sphingosine kinase 1 inhibitors.
Xiang Y; Asmussen G; Booker M; Hirth B; Kane JL; Liao J; Noson KD; Yee C
Bioorg Med Chem Lett; 2009 Nov; 19(21):6119-21. PubMed ID: 19800228
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine kinase 1 (SK1) allosteric inhibitors that target the dimerization site.
Bayraktar O; Ozkirimli E; Ulgen K
Comput Biol Chem; 2017 Aug; 69():64-76. PubMed ID: 28587987
[TBL] [Abstract][Full Text] [Related]
16. Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors.
Mathews TP; Kennedy AJ; Kharel Y; Kennedy PC; Nicoara O; Sunkara M; Morris AJ; Wamhoff BR; Lynch KR; Macdonald TL
J Med Chem; 2010 Apr; 53(7):2766-78. PubMed ID: 20205392
[TBL] [Abstract][Full Text] [Related]
17. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
[TBL] [Abstract][Full Text] [Related]
18. Drugging sphingosine kinases.
Santos WL; Lynch KR
ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of targeting SK1 in human cancers.
Alshaker H; Sauer L; Monteil D; Ottaviani S; Srivats S; Böhler T; Pchejetski D
Adv Cancer Res; 2013; 117():143-200. PubMed ID: 23290780
[TBL] [Abstract][Full Text] [Related]
20. [Sphingosine kinase 1 and tumor].
Zhang CX; He HW; Shao RG
Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
